Literature DB >> 9045987

Dystrophin expression in heterozygous mdx/+ mice indicates imprinting of X chromosome inactivation by parent-of-origin-, tissue-, strain- and position-dependent factors.

R E Bittner1, I Popoff, S Shorny, H Höger, F Wachtler.   

Abstract

Inactivation of one X chromosome (X inactivation) in female mammals results in dosage compensation of X-chromosomally encoded genes between sexes. In the embryo proper of most mammals X inactivation is thought to occur at random with respect to the parental origin of the X chromosome. We determined on the cellular level the expression of the X-chromosomally encoded protein dystrophin in skeletal and cardiac muscle of female mice heterozygous for a null mutation of the dystrophin gene (mdx/+). In all muscles investigated (cardiac, anterior venter of digastric muscle, biceps brachii and tibialis anterior muscle) we found a mosaic expression of dystrophin-expressing versus non-expressing cells and determined their proportion with respect to the parental origin of the X chromosome. In all groups of mdx/+ mice the level and pattern of dystrophin expression were found to be dependent on the parental origin of the mdx mutation. Additionally, the extent of dystrophin expression was clearly dependent on the mouse strains (C57BL/10 and BALB/c) used to produce heterozygous mdx/+ mice. Variable differences and patterns of dystrophin expression in skeletal versus cardiac muscle were found that were strictly dependent on the parental source of the mdx mutation and the strain used to breed mdx/+ mice. Moreover, dystrophin expression was found to be different between the right side and the left side of the body in individual muscles, and this difference was clearly dependent on the parental origin of the X chromosome. Our data provide evidence that in the mouse embryo proper there is a non-random distribution of cells showing inactivation of the paternal versus the maternal X chromosome in skeletal and cardiac muscle, indicating a non-random X-inactivation. Besides gametic imprinting, strain-, tissue and position-dependent factors also appear to bias X inactivation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045987     DOI: 10.1007/s004290050036

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  9 in total

1.  Genetic and parent-of-origin influences on X chromosome choice in Xce heterozygous mice.

Authors:  Lisa Helbling Chadwick; Huntington F Willard
Journal:  Mamm Genome       Date:  2005-10-20       Impact factor: 2.957

2.  Comparative methylation analysis of murine transgenes that undergo or escape X-chromosome inactivation.

Authors:  M A Goldman; P S Reeves; C M Wirth; W J Zupko; M A Wong; S Edelhoff; C M Disteche
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

Review 3.  Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation.

Authors:  Graça Almeida-Porada; Christopher Porada; Esmail D Zanjani
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

4.  Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice.

Authors:  Yongping Yue; Jeffrey W Skimming; Mingju Liu; Tammy Strawn; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2004-06-09       Impact factor: 6.150

Review 5.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

6.  Dosage compensation is less effective in birds than in mammals.

Authors:  Yuichiro Itoh; Esther Melamed; Xia Yang; Kathy Kampf; Susanna Wang; Nadir Yehya; Atila Van Nas; Kirstin Replogle; Mark R Band; David F Clayton; Eric E Schadt; Aldons J Lusis; Arthur P Arnold
Journal:  J Biol       Date:  2007

Review 7.  Known unknowns for allele-specific expression and genomic imprinting effects.

Authors:  Christopher Gregg
Journal:  F1000Prime Rep       Date:  2014-09-04

8.  Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.

Authors:  Tirsa L E van Westering; Yulia Lomonosova; Anna M L Coenen-Stass; Corinne A Betts; Amarjit Bhomra; Margriet Hulsker; Lucy E Clark; Graham McClorey; Annemieke Aartsma-Rus; Maaike van Putten; Matthew J A Wood; Thomas C Roberts
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-12-17       Impact factor: 12.910

9.  Genetic architecture of skewed X inactivation in the laboratory mouse.

Authors:  John D Calaway; Alan B Lenarcic; John P Didion; Jeremy R Wang; Jeremy B Searle; Leonard McMillan; William Valdar; Fernando Pardo-Manuel de Villena
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.